Institution
Cancer Hospital of Chinese Academy of Medical Sciences
Also known as: Ritan Hospital · 中国医学科学院肿瘤医院
- 242running trials
- 68closed trials
- 16,210publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer
Not yet recruiting
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
Recruiting
GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)
Recruiting
Recruiting
Recruiting
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
Recruiting
Not yet recruiting
Not yet recruiting
Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)
Active, not recruiting
Not yet recruiting
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer
Recruiting
Not yet recruiting
Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer
Recruiting
Recruiting
Recruiting
A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Recruiting
Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
Recruiting
Recruiting
Recruiting
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Recruiting
Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
Not yet recruiting
IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer
Recruiting
Response-Based Local Therapy for Regionally Advanced Breast Cancer
Recruiting
Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
Recruiting
Recruiting
Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
Not yet recruiting
Enrolling by invitation
Showing 50 of 242.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer53 recruiting
- Metastatic breast cancer26 recruiting
- Gastric and oesophageal cancer19 recruiting
- Liver and biliary tract cancer14 recruiting
- Colorectal cancer12 recruiting
- Triple-negative breast cancer11 recruiting
- Childhood cancers10 recruiting
- Ovarian cancer9 recruiting
- Prostate cancer8 recruiting
- Cervical cancer6 recruiting
- Diffuse large B-cell lymphoma5 recruiting
- Endometrial cancer5 recruiting
- Brain metastases4 recruiting
- Kidney cancer4 recruiting
- Mesothelioma4 recruiting
- Pancreatic cancer4 recruiting
- Bladder cancer3 recruiting
- Head and neck cancer3 recruiting
- Sarcoma3 recruiting
- Thyroid cancer3 recruiting
- Melanoma2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Follicular lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
Closed trials
Completed
Terminated
Terminated
Completed
The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer Patients
Completed
Completed
Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
Withdrawn
Completed
Completed
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
Completed
Completed
Completed
Completed
Completed
Completed
Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer
Terminated
Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)
Completed
Terminated
Completed
Completed
Withdrawn
Completed
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
Completed
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
Completed
Completed
Completed
Completed
Completed
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Completed
Study of JS004 Combined With Toripalimab for Advanced Lung Cancer
Completed
Terminated
AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer
Completed
Completed
Completed
Completed
JAB-3068 Activity in Adult Patients With Advanced Solid Tumors
Completed
Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer
Completed
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Completed
Completed
Keynatinib in Treated Patients With NSCLC and Brain Metastases
Completed
Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors
Completed
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
Completed
Completed
Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit
Completed
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
Completed
Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects
Completed
Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors
Completed
Completed
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Completed
Showing 50 of 68.
Registry name variants (35)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, 100021
220 trials
Cancer Hospital Chinese Academy of Medical Science
Beijing, Beijing Municipality 100021
30 trials
Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College
Beijing, Chaoyang 100021
8 trials
Chinese Academy of Medical Sciences Cancer Hospital
Beijing, 100021
6 trials
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Beijing, 100021
6 trials
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, 100021
6 trials
Cancer Hospital of Chinese Academy of Medical Sciences
Beijing, Beijing Municipality 100021
5 trials
Cancer Hospital of Chinese Academy of Medical Science
Beijing, 1000021
3 trials
Cancer Hospital Chinese Academy of Medical Science (Site 0117)
Beijing, Beijing Municipality 100021
2 trials
Cancer Hopital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality 100000
1 trial
Cancer Hospital, Chinese Academy of Medical Sciences - 3211
Beijing, Beijing Municipality
1 trial
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing 100021
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
Beijing, Beijing Municipality 100021
1 trial
Contact: Jie Wang, Doctor
Cancer Hospital Chinese Academy of Medical Sciences (CAMS)
Beijing, 100021
1 trial
Cancer Hospital Chinese Academy of Medical Sciences - Head and Neck Surgery Department
Beijing, Beijing Municipality 100021
1 trial
Contact: Nadene Zack, MS
Cancer Hospital - Chinese Academy of Medical Sciences
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital - Chinese Academy Of Medical Sciences
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital - Chinese Academy of Medical Sciences
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital - Chinese Academy of Medical Sciences
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital Chinese Academy of Medical Science (Site 2635)
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital Chinese Academy of Medical Sciences/Medical Oncology Department
Beijing, Beijing Municipality 100021
1 trial
Contact: Yan Wang, Site 007-050-Ph3
Cancer Hospital Chinese Academy of Medical Sciences (Site 0100)
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital Chinese Academy of Medical Sciences (Site 0156)
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital Chinese Academy of Medical Sciences (Site 0435)
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital Chinese Academy of Medical Sciences (Site 0801)
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital Chinese Academy of Medical Sciences (Site 2403)
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital Chinese Academy of Medical Sciences (Site 2421)
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital Chinese Academy of Medical Sciences (Site 3100)
Beijing, Beijing Municipality 100021
1 trial
NCT07060807A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Contact: Toll Free Number
Cancer Hospital Chinese Academy of Medical Sciences (Site 3104)
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital Chinese Academy of Medical Sciences (Site 3213)
Beijing, Beijing Municipality 100021
1 trial
Cancer Hospital of the Chinese Academy of Medical Sciences
Beijing
1 trial
Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College
Beijing, 100021
1 trial
Internal Medicine, Chinese Academy of Medical Sciences Cancer Hospital
Beijing, 100021
1 trial
National Cancer Center/Chinese Academy of Medical Sciences Cancer Hospital
Beijing, Beijing Municipality 100021
1 trial
Contact: Ning Li, Doctor
National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality
1 trial
NCT07733830Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
Contact: Wenyang Liu, MD
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer220 works · 96 trials
- Liver and biliary tract cancer99 works · 21 trials
- Gastric and oesophageal cancer88 works · 35 trials
- Colorectal cancer86 works · 23 trials
- Ovarian cancer37 works · 16 trials
- Brain metastases32 works · 7 trials
- Cervical cancer32 works · 12 trials
- Triple-negative breast cancer31 works · 18 trials
- Pancreatic cancer26 works · 6 trials
- Sarcoma24 works · 5 trials
- Kidney cancer22 works · 8 trials
- Metastatic breast cancer22 works · 45 trials
- Neuroendocrine tumours16 works · 0 trials
- Thyroid cancer12 works · 3 trials
- Hodgkin lymphoma11 works · 0 trials
- Diffuse large B-cell lymphoma9 works · 6 trials
- Thymoma and thymic carcinoma4 works · 0 trials
Institution data: ROR 03x937183 (CC0-1.0)Updated 15 Nov 2026